Kailera Therapeutics, Inc. (KLRA) free cash flow

Free cash flow · fiscal 2025
-$122.30M

Only 1 fiscal year of free cash flow is on record here for Kailera Therapeutics, Inc. (KLRA); a history needs at least 3. Figures as of 18 Nov 2026, 12:20 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$122.30M
Fiscal years on record
12025–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of free cash flow needs at least 3 fiscal years; one is on record here for Kailera Therapeutics, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Kailera Therapeutics, Inc. free cash flow, year by year

Kailera Therapeutics, Inc. (KLRA) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$122.30M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on KLRA

Kailera Therapeutics, Inc., figure by figure

Kailera Therapeutics, Inc. (KLRA) overview: price, valuation and scorecard

Kailera Therapeutics, Inc. free cash flow: questions and answers

How is Kailera Therapeutics, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kailera Therapeutics, Inc. (KLRA) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/KLRA/free-cash-flow

Underlying data: Yahoo Finance.